Cancer incidence and mortality in China, 2015

Background: National Cancer Center (NCC) updated nationwide cancer statistics using population-based cancer registry data in 2015. Methods: 501 cancer registries submitted data, among which 368 registries with high quality data were included in analysis. Numbers of nationwide new cancer cases and de...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Siwei Zhang, Kexin Sun, Rongshou Zheng, Hongmei Zeng, Shaoming Wang, Ru Chen, Wenqiang Wei, Jie He
Formato:	article
Lenguaje:	EN
Publicado:	Elsevier 2021
Materias:	Cancer registry Incidence Mortality Epidemiology China Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Acceso en línea:	https://doaj.org/article/450f0f8a08e44ba7b6b06addda467e1b
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:450f0f8a08e44ba7b6b06addda467e1b
record_format	dspace
spelling	oai:doaj.org-article:450f0f8a08e44ba7b6b06addda467e1b2021-12-01T05:06:25ZCancer incidence and mortality in China, 20152667-005410.1016/j.jncc.2020.12.001https://doaj.org/article/450f0f8a08e44ba7b6b06addda467e1b2021-03-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S2667005420300016https://doaj.org/toc/2667-0054Background: National Cancer Center (NCC) updated nationwide cancer statistics using population-based cancer registry data in 2015. Methods: 501 cancer registries submitted data, among which 368 registries with high quality data were included in analysis. Numbers of nationwide new cancer cases and deaths were estimated using incidence and mortality rates and corresponding national population stratified by area, sex, age group and cancer site. The world Segi's population was applied for the calculation of age-standardized rates. Results: About 3,929,000 new cancer cases were diagnosed. The crude incidence rate was 285.83/100,000 and the age-standardized incidence rate by world standard population (ASIRW) was 186.39/100,000. ASIRW was higher in urban areas than in rural areas. South China had the highest ASIRW while Southwest China had the lowest ASIRW. Age-specific incidence rate was higher in males for population younger than 20 years or over 49 years. From 2000 to 2015, the ASIRWs for esophageal cancer, gastric cancer and liver cancer decreased significantly. The ASIRWs for colorectal cancer in whole population and for lung cancer, breast cancer, cervix cancer, uterus cancer and thyroid cancer in females increased significantly. 2,338,000 cancer deaths were reported. The crude mortality rate was 170.05/100,000 and the age standardized mortality rate by world standard population (ASMRW) was 105.84/100,000. ASMRW was higher in rural areas than in urban areas. Central China had the highest ASMRW while North China had the lowest ASMRW. Age-specific mortality rates in males were higher than that in females in every age group. From 2000 to 2015, the ASMRWs for esophageal cancer, gastric cancer, liver cancer and lung cancer decreased significantly. The ASMRWs for colorectal cancer, pancreas cancer and prostate cancer in males and for breast cancer, cervix cancer and thyroid cancer in females increased significantly. Conclusions: Cancer has become a major life-threatening disease in China. Disease burdens differed across areas. Disease burdens for esophageal cancer, gastric cancer and liver cancer have decreased, while disease burdens for colorectal cancer, female breast cancer, cervix cancer and thyroid cancer have increased over the last 15 years. National and regional initiative for cancer prevention and control should be prioritized.Siwei ZhangKexin SunRongshou ZhengHongmei ZengShaoming WangRu ChenWenqiang WeiJie HeElsevierarticleCancer registryIncidenceMortalityEpidemiologyChinaNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENJournal of the National Cancer Center, Vol 1, Iss 1, Pp 2-11 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Cancer registry Incidence Mortality Epidemiology China Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
spellingShingle	Cancer registry Incidence Mortality Epidemiology China Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 Siwei Zhang Kexin Sun Rongshou Zheng Hongmei Zeng Shaoming Wang Ru Chen Wenqiang Wei Jie He Cancer incidence and mortality in China, 2015
description	Background: National Cancer Center (NCC) updated nationwide cancer statistics using population-based cancer registry data in 2015. Methods: 501 cancer registries submitted data, among which 368 registries with high quality data were included in analysis. Numbers of nationwide new cancer cases and deaths were estimated using incidence and mortality rates and corresponding national population stratified by area, sex, age group and cancer site. The world Segi's population was applied for the calculation of age-standardized rates. Results: About 3,929,000 new cancer cases were diagnosed. The crude incidence rate was 285.83/100,000 and the age-standardized incidence rate by world standard population (ASIRW) was 186.39/100,000. ASIRW was higher in urban areas than in rural areas. South China had the highest ASIRW while Southwest China had the lowest ASIRW. Age-specific incidence rate was higher in males for population younger than 20 years or over 49 years. From 2000 to 2015, the ASIRWs for esophageal cancer, gastric cancer and liver cancer decreased significantly. The ASIRWs for colorectal cancer in whole population and for lung cancer, breast cancer, cervix cancer, uterus cancer and thyroid cancer in females increased significantly. 2,338,000 cancer deaths were reported. The crude mortality rate was 170.05/100,000 and the age standardized mortality rate by world standard population (ASMRW) was 105.84/100,000. ASMRW was higher in rural areas than in urban areas. Central China had the highest ASMRW while North China had the lowest ASMRW. Age-specific mortality rates in males were higher than that in females in every age group. From 2000 to 2015, the ASMRWs for esophageal cancer, gastric cancer, liver cancer and lung cancer decreased significantly. The ASMRWs for colorectal cancer, pancreas cancer and prostate cancer in males and for breast cancer, cervix cancer and thyroid cancer in females increased significantly. Conclusions: Cancer has become a major life-threatening disease in China. Disease burdens differed across areas. Disease burdens for esophageal cancer, gastric cancer and liver cancer have decreased, while disease burdens for colorectal cancer, female breast cancer, cervix cancer and thyroid cancer have increased over the last 15 years. National and regional initiative for cancer prevention and control should be prioritized.
format	article
author	Siwei Zhang Kexin Sun Rongshou Zheng Hongmei Zeng Shaoming Wang Ru Chen Wenqiang Wei Jie He
author_facet	Siwei Zhang Kexin Sun Rongshou Zheng Hongmei Zeng Shaoming Wang Ru Chen Wenqiang Wei Jie He
author_sort	Siwei Zhang
title	Cancer incidence and mortality in China, 2015
title_short	Cancer incidence and mortality in China, 2015
title_full	Cancer incidence and mortality in China, 2015
title_fullStr	Cancer incidence and mortality in China, 2015
title_full_unstemmed	Cancer incidence and mortality in China, 2015
title_sort	cancer incidence and mortality in china, 2015
publisher	Elsevier
publishDate	2021
url	https://doaj.org/article/450f0f8a08e44ba7b6b06addda467e1b
work_keys_str_mv	AT siweizhang cancerincidenceandmortalityinchina2015 AT kexinsun cancerincidenceandmortalityinchina2015 AT rongshouzheng cancerincidenceandmortalityinchina2015 AT hongmeizeng cancerincidenceandmortalityinchina2015 AT shaomingwang cancerincidenceandmortalityinchina2015 AT ruchen cancerincidenceandmortalityinchina2015 AT wenqiangwei cancerincidenceandmortalityinchina2015 AT jiehe cancerincidenceandmortalityinchina2015
_version_	1718405538133311488

Cancer incidence and mortality in China, 2015

Ejemplares similares